HepaRegeniX
GermanyEntry
2016
Hold
10yr
Status
Active
Who owns HepaRegeniX?
HepaRegeniX is a German Biotech company, currently owned by Novo Holdings since 2016 and 2 other investors.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Most recent investor
High-Tech Gruenderfonds (HTGF)HTGF II · 2011 · VC
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-held by Novo Holdings, Boehringer Ingelheim Venture Fund and High-Tech Gruenderfonds (HTGF) since 2016.
Co-invest · 3 holders · 2016 · present
Novo HoldingsActive
2016 · present(10yr) · Novo Holdings Venture Investments · 1999 · VC
More from HTGF II
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns HepaRegeniX?
HepaRegeniX is currently owned by Novo Holdings, Boehringer Ingelheim Venture Fund and 1 other, through HTGF II, since 2016.
When did Novo Holdings and 2 others acquire HepaRegeniX?
Novo Holdings and 2 others acquired HepaRegeniX in 2016.
Who has owned HepaRegeniX over time?
HepaRegeniX has been through 3 private-equity ownership periods: Novo Holdings · via Novo Holdings Venture Investments · since 2016; Boehringer Ingelheim Venture Fund · via Boehringer Ingelheim Venture Fund · since 2016; High-Tech Gruenderfonds (HTGF) · via HTGF II · since 2016.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue